Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Oncology Research Consortium (ORC) is a clinical research organization and network that facilitates access to NCI-sponsored and industry-funded clinical trials within community settings. It primarily operates as a bridge between academic research institutions and community-based oncology practices, ensuring that patients have access to cutting-edge cancer therapies regardless of their geographic location. The consortium manages regulatory compliance, data collection, and trial site coordination for a wide range of oncological indications. By leveraging a broad network of affiliated physicians and hospitals, ORC accelerates patient enrollment and enhances the diversity of clinical trial participants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oncology Research Consortium.